NCT07455617 2026-03-06
Study of ABO2102 in KRAS-Mutated Solid Tumors
Suzhou Abogen Biosciences Co., Ltd.
Phase 1 Not yet recruiting
Clinical Trials
18 trialsNCT07438782 2026-02-27
First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors
GlaxoSmithKline
Phase 1 Not yet recruiting
NCT07403721 2026-02-11
AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
Amgen
Phase 1 Not yet recruiting
NCT07385703 2026-02-04
Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3 Not yet recruiting
NCT07368127 2026-01-26
A Study of TPD3310 in Patients With Advanced Malignant Tumors
TAIBIDI PHARMACEUTICAL TECHNOLOGY(SHIJIAZHUANG) CO.,LTD.
Phase 1 Not yet recruiting
NCT06724042 2025-12-10
Study of ISM5939 in Patients With Advanced and/or Metastatic Solid Tumors
InSilico Medicine Hong Kong Limited
Phase 1 Not yet recruiting
NCT07057349 2025-07-09
CSB-321 Ph 1 in Immunotherapy for the Treatment of Cancer
Cytosite Biopharma Inc.
Phase 1 Not yet recruiting
NCT06961188 2025-05-07
Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight Gain in Pre-Cachexia and Cachexia Stages Key Terminology Analysis
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 3 Not yet recruiting
NCT06942767 2025-04-27
Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Qilu Pharmaceutical Co., Ltd.
Phase 2 Not yet recruiting
NCT06883058 2025-03-19
CASA pre-pilot
Ponce Medical School Foundation, Inc.
Phase NA Not yet recruiting
NCT06389526 2024-09-19
A Study of CHS-1000 in Participants With Advanced or Metastatic Solid Tumors
Coherus Oncology, Inc.
Phase 1 Not yet recruiting
NCT06544070 2024-08-09
CAPYBARA
Entia Ltd
Not yet recruiting
NCT05474859 2024-07-31
Subjects With Advanced or Metastatic Solid Tumor Malignancies
Xenthera, Inc.
Phase 1 Not yet recruiting
NCT05435365 2024-01-02
Investigating The Experiences of Patients In Immunotherapy Clinical Trials
Power Life Sciences Inc.
Not yet recruiting
NCT06099990 2023-10-25
Dalpiciclib Isethionate Tablets Combined With Abiraterone Acetate Tablets (I) and Prednisone Tablets (AA-P) Versus Placebo Combined With AA-P in Treatment of High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC)
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Not yet recruiting
NCT05926362 2023-07-03
CaVeP-DC
Entia Ltd
Not yet recruiting
NCT05929547 2023-07-03
Patient Perspectives in Squamous Cell Carcinoma Clinical Trials
Power Life Sciences Inc.
Not yet recruiting
NCT04891952 2021-05-19
Measuring the Impact of Onco4D® Guidance on Chemotherapy Selection and Outcomes
Animated Dynamics, Inc.
Not yet recruiting